Celyad SA (CYAD)

Currency in EUR
0.25
0.00(0.00%)
Real-time Data·
Advertisement
CYAD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.230.25
52 wk Range
0.160.65
Key Statistics
Prev. Close
0.25
Open
0.23
Day's Range
0.23-0.25
52 wk Range
0.16-0.65
Volume
2.07K
Average Volume (3m)
16.13K
1-Year Change
-37.3737%
Book Value / Share
0.05
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CYAD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Celyad SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
29/05/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Celyad (CYAD) Income Statement & Profits

Compare CYAD to Peers and Sector

Metrics to compare
CYAD
Peers
Sector
Relationship
P/E Ratio
13.5x−0.2x−0.4x
PEG Ratio
0.12−0.070.00
Price/Book
4.6x1.0x2.6x
Price / LTM Sales
532.9x0.9x3.0x
Upside (Analyst Target)
-136.7%51.8%
Fair Value Upside
Unlock17.3%7.2%Unlock

Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
45.37K0.10%11.34K
Other Institutional Investors
30.40M67.92%7.60M
Public Companies & Retail Investors
14.32M31.98%3.58M
Total
44.76M100.00%11.19M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Fortress Investment Group LLC58.51%26,191,9876,548
Tolefi S.A.9.40%4,209,1631,052

People Also Watch

4.105
ALMDT
-0.48%
4.10
ADOC
+0.54%
0.2895
ALSEN
-1.19%
114.40
LOUP
-0.52%
26.40
LBIRD
-0.94%

FAQ

What Is the Celyad (Brussels: CYAD) Share Price Today?

The Celyad stock price today is 0.25 EUR.

What Stock Exchange Does Celyad (CYAD) Trade On?

Celyad is listed and trades on the Brussels Stock Exchange.

What Is the Ticker (Stock Symbol) for Celyad?

The stock symbol (also called a 'ticker') for Celyad is "CYAD."

What Is the Current Celyad Market Capitalisation?

As of today, Celyad (Brussels: CYAD) market cap is 11.19M EUR.

What Is Celyad's (CYAD) Earnings Per Share (TTM)?

The Celyad EPS is currently 0.02 (Trailing Twelve Months).

When Is the Next Celyad Earnings Date?

Celyad's next earnings report will be released on 23/09/2026.

Is CYAD a Buy or Sell From a Technical Analyst Perspective?

Based on today's Celyad moving averages and other technical indicators, the daily buy/sell signal for CYAD stock is Strong Sell.

How Many Times Has Celyad Stock Split?

Celyad has split 0 times. (See the CYAD stock split history page for full effective split date and price information.)

How Many Employees Does Celyad Have?

Celyad has 5 employees, based on their latest Companies House report.

What is the current trading status of Celyad (Brussels: CYAD)?

As of 06/08/2026, Celyad (CYAD) is trading at a share price of 0.25 EUR, with a previous close of 0.25 EUR. The stock has fluctuated within a day range of 0.23 EUR to 0.25 EUR, while its 52-week range spans from 0.16 EUR to 0.65 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.